A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PANSS-EC / Positive and Negative Syndrome Scale-Excited Component

[Related PubMed/MEDLINE]
Total Number of Papers: 33
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PANSS-EC  (>> Co-occurring Abbreviation)
Long Form:   Positive and Negative Syndrome Scale-Excited Component
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Cytokines in agitated and non-agitated patients admitted to an acute psychiatric department: A cross-sectional study. IFN, IL, TGF, TNF
2018 Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia. ---
2018 Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation). BARS, CGI-I, CI, MD, MOAS, RCTs, RR
2018 Safety and effectiveness of rapid-acting intra-muscular olanzapine for agitation associated with schizophrenia - Japan postmarketing surveillance study. ADRs, IM, PMS, TEAEs
2017 Efficacy of lurasidone in the treatment of agitation: A post hoc analysis of five short-term studies in acutely ill patients with schizophrenia. LS
2017 Prevalence and risk factors of agitation in newly hospitalized schizophrenia patients in China: An observational survey. BARS
2017 Response to inhaled loxapine in patients with schizophrenia or bipolar I disorder: PANSS-EC responder analyses. ---
2016 Treatment of agitation in the acute psychiatric setting. An observational study of the effectiveness of intramuscular psychotropic medication. ---
2015 Intramuscular olanzapine for agitated patients: A systematic review and meta-analysis of randomized controlled trials. ACES, HAL, IM, LOR-IM, OLA-IM, RCTs, ZIP
10  2015 Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial. ACES, IM
11  2014 A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia. BARS, DIEPSS, IM
12  2014 A single-dose, randomized, double-blind, placebo-controlled trial of sublingual asenapine for acute agitation. ---
13  2014 Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia. ESS, UCSD
14  2013 A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in agitated elderly patients with schizophrenia. ACES, AIMS, BARS, DIEPSS, IM
15  2013 A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophrenia. ACES, AIMS, BARS, DIEPSS, DSM, IM
16  2013 A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation. IM, TEAEs
17  2013 Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents. ---
18  2013 Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate. CGI-BP, MEMAP, SCIP, YMRS
19  2012 Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia. RIS-OS
20  2012 Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine. ---
21  2011 Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial. BARS, CGI-I
22  2011 Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. CGI-I
23  2010 Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study. CGI-S
24  2009 Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation. CGI-S, IM
25  2009 Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective study. DIEPSS, NAMA
26  2008 Clinical characteristics of agitated psychotic patients treated with an oral antipsychotics attended in the emergency room setting: NATURA study. ACES, CGI-S, PES
27  2008 Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication. ---
28  2008 Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. ---
29  2008 Validation of a Clinical Global Impression Scale for Aggression (CGI-A) in a sample of 558 psychiatric patients. CGI-A, CGI-A
30  2006 A pilot, open-label safety study of quetiapine for treatment of moderate psychotic agitation in the emergency setting. BARS
31  2003 A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy. EPS, IM
32  2003 Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation. RIDE, UCP
33  2002 A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. IM